Literature DB >> 29049986

New Diagnostic Criteria of Polycystic Ovarian Morphology for Adolescents: Impact on Prevalence and Hormonal Profile.

Paulina M Merino1, Claudio Villarroel1, Cristián Jesam1, Patricia López1,2, Ethel Codner1.   

Abstract

BACKGROUND: The ultrasonographic criteria used to identify polycystic ovarian morphology (PCOM) during adolescence have changed over time. Recently, a Worldwide Pediatric Consensus (PedC) defined PCOM using stricter criteria than the previous recommendations of the Rotterdam Consensus (RC) and Androgen Excess-Polycystic Ovarian Syndrome Society (AES/PCOS) criteria. The aim of this study was to determine the prevalence of PCOM in healthy adolescents according to the 3 reported diagnostic criteria and compare the hormonal profile in females with and without PCOM based on the PedC criteria.
METHODS: Nonobese adolescents (n = 102) with regular menstrual cycles were studied. Transabdominal ultrasound and hormonal profiles were assessed during the follicular phase. PCOM was defined on the basis of the 3 published criteria.
RESULTS: On the basis of the PedC, RC, and AES/PCOS criteria, PCOM was diagnosed in 13, 34, and 24% of adolescents, respectively. Adolescents with and without PCOM according to the PedC criteria had similar androgen levels. Serum anti-Müllerian hormone (AMH) levels were elevated in adolescents with PCOM, irrespective of the criteria used.
CONCLUSIONS: Use of the new PedC diagnostic criteria for PCOM results in a lower prevalence of this ultrasonographic pattern in adolescents, but this condition is not associated with hyperandrogenism. Elevated AMH is associated with PCOM in adolescents regardless of the criteria used to determine the ultrasonographic pattern.
© 2017 S. Karger AG, Basel.

Entities:  

Keywords:  Adolescence; Anti-Müllerian hormone; Hyperandrogenism; Polycystic ovarian morphology; Polycystic ovarian syndrome

Mesh:

Substances:

Year:  2017        PMID: 29049986     DOI: 10.1159/000481532

Source DB:  PubMed          Journal:  Horm Res Paediatr        ISSN: 1663-2818            Impact factor:   2.852


  5 in total

1.  Comparison of metabolic and obesity biomarkers between adolescent and adult women with polycystic ovary syndrome.

Authors:  Sebastião Freitas de Medeiros; Matheus Antônio Souto de Medeiros; Bruna Barcelo Barbosa; Márcia Marly Winck Yamamoto; Gustavo Arantes Rosa Maciel
Journal:  Arch Gynecol Obstet       Date:  2020-11-17       Impact factor: 2.344

2.  The Relationship of Anti-Mullerian Hormone in Polycystic Ovary Syndrome Patients with Different Subgroups.

Authors:  Yu Ran; Qiang Yi; Cong Li
Journal:  Diabetes Metab Syndr Obes       Date:  2021-03-25       Impact factor: 3.168

3.  Anti-Müllerian Hormone Levels in Adolescence in Relation to Long-term Follow-up for Presence of Polycystic Ovary Syndrome.

Authors:  Mirte R Caanen; Henrike E Peters; Peter M van de Ven; Anne M F M Jüttner; Joop S E Laven; Marcel H A van Hooff; Cornelis B Lambalk
Journal:  J Clin Endocrinol Metab       Date:  2021-03-08       Impact factor: 5.958

Review 4.  Criteria for Diagnosis of Polycystic Ovary Syndrome during Adolescence: Literature Review.

Authors:  Alexia S Peña; Ethel Codner; Selma Witchel
Journal:  Diagnostics (Basel)       Date:  2022-08-10

5.  The Relevant Hormonal Levels and Diagnostic Features of Polycystic Ovary Syndrome in Adolescents.

Authors:  Elena Khashchenko; Elena Uvarova; Mikhail Vysokikh; Tatyana Ivanets; Lyubov Krechetova; Nadezhda Tarasova; Iuliia Sukhanova; Fatima Mamedova; Pavel Borovikov; Ivan Balashov; Gennady Sukhikh
Journal:  J Clin Med       Date:  2020-06-11       Impact factor: 4.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.